Gamida Cell - Cell Therapy Technologies

Interviews

Professor Patrick Stiff comments on the study of StemEx® for leukemia in a video interview, November 2, 2009.

Professor Patrick Stiff is the Director of the Cardinal Bernardin Cancer Center, Loyola University Stritch School of Medicine, Chicago.

  • What is the advantage of cord blood over bone marrow transplantation?
  • What has been the response of patients and doctors to the ExCell study?
  • What is the future of cord blood transplantation?
  • What are your impressions of the ExCell trial?

Professor Guillermo Sanz comments on the study of StemEx® for leukemia in a video interview, November 2, 2009.

Professor Guillermo Sanz is the Head of Clinical Hematology at the Department of Hematology of Hospital Universitario La Fe, Valencia.

  • What is the advantage of cord blood over bone marrow transplantation?
  • Why is the ExCell study of StemEx® important?
  • What is the advantage of StemEx®?
  • What are your impressions of the ExCell trial?

Learn more about StemEx Clinical Trial